infection

no-infection

P

logistics

n

265

309

Age, median [Q1, Q3]

56.00 [47.00, 66.00]

53.00 [41.00, 64.00]

0.006

0.083

Male, n

164

188

0.864

/

Male, (%)

61.89%

60.84%

ethnicity

white, n

163

182

white, (%)

61.51%

58.90%

BLACK/AFRICAN AMERICAN, n

27

42

BLACK/AFRICAN AMERICAN, (%)

10.19%

13.59%

AMERICAN INDIAN/ALASKA NATIVE, n

1

1

AMERICAN INDIAN/ALASKA NATIVE, (%)

0.38%

0.32%

PORTUGUESE, n

4

1

PORTUGUESE, (%)

1.51%

0.32%

UNKNOWN, n

31

39

UNKNOWN, (%)

11.70%

12.62%

ASIAN, n

8

12

ASIAN, (%)

3.02%

3.88%

OTHER, n

12

11

OTHER, (%)

4.53%

3.56%

HISPANIC/LATINO, n

9

16

HISPANIC/LATINO, (%)

3.40%

5.18%

UNABLE TO OBTAIN, n

10

5

UNABLE TO OBTAIN, (%)

3.77%

1.62%

Aps III, median [Q1, Q3]

67.00 [52.00, 93.00]

50.00 [36.00, 72.00]

<0.001*

<0.001*

inSOFA, median [Q1, Q3]

2.00 [0, 4.00]

1.00 [0, 3.00]

0.008

0.289

▲SOFA, median [Q1, Q3]

1.00 [−1.00, 3.00]

1.00 [−1.00, 2.00]

0.120

/

Glu_meana (mmol/L), median [Q1, Q3]

7.80 [6.63, 9.23]

7.70 [6.52, 9.46]

0.983

/

Glu_cvb, median [Q1, Q3]

0.25 [0.19, 0.35]

0.22 [0.16, 0.32]

0.013

0.198

Glu_frequency* (n/day), median [Q1, Q3]

4.49 [3.60, 5.74]

4.75 [3.45, 6.97]

0.098

0.003

LOS in ICUc, median [Q1, Q3]

7.15 [3.35, 16.87]

3.95 [2.77, 7.00]

<0.001*

/

LOS in hospitald, median [Q1, Q3]

20.74 [11.81, 33.23]

12.73 [7.69, 19.89]

<0.001*

/

antibiotic day, median [Q1, Q3]

2.00 [0, 4.00]

1.00 [0, 3.00]

<0.001*

/

die, n

52

28

<0.001*

0.520

die, (%)

19.62%

9.06%

blood-infection, n

157

0

/

/

blood-infection, (%)

59.25%

0.00%

Abdominal-infection, n

75

0

/

/

Abdominal-infection, (%)

28.30%

0.00%

urinary-infection, n

64

0

/

/

urinary-infection, (%)

24.15%

0.00%

respiratory-infection, n

85

0

/

/

respiratory-infection, (%)

32.08%

0.00%

diabetes, n

80

119

0.043

0.176

diabetes, (%)

30.19%

38.51%

hypoglycemia, n

6

5

0.762

/

hypoglycemia, (%)

3.66%

2.66%

hyperlipidemia, n

64

51

0.028

0.033

hyperlipidemia, (%)

24.15%

16.50%